Evidence map›Paper›PMID 37131164›Full record

ArticleBMC infectious diseases2023

Incidence and trends of 17 notifiable bacterial infectious diseases in China, 2004-2019.

Yuliang Zhu, Shenghong Lin, Shuaibing Dong, Cuihong Zhang, Lusha Shi, Xiang Ren, Zhongjie Li, Liping Wang, Liqun Fang

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Epidemiological characteristics of syphilis in mainland China, 2004 to 2019.The Journal of international medical research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yuliang Zhu *Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC, 155 Changbai Road, Changping District, Beijing, China.
Shenghong Lin *The State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing, 100071, China.
Shuaibing DongInstitute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing Research Center for Preventive medicine, Beijing, China.
Cuihong ZhangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC, 155 Changbai Road, Changping District, Beijing, China.
Lusha ShiDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC, 155 Changbai Road, Changping District, Beijing, China.
Xiang RenDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC, 155 Changbai Road, Changping District, Beijing, China.
Zhongjie LiDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC, 155 Changbai Road, Changping District, Beijing, China.
Liping WangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, China CDC, 155 Changbai Road, Changping District, Beijing, China. wanglp@chinacdc.cn.
Liqun FangThe State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing, 100071, China. fang_lq@163.com.
Chinese Center For Disease Control and Prevention · CNInstitute of Microbiology · CNBeijing Center for Disease Prevention and Control · CNShanxi University · CN

Funding

National Natural Science Foundation of China No. 91846302National Science and Technology Major Project of China No. 2018ZX10713001the Key Research and Development Program of China 2019YFC1200604
6 · The paper itself

Abstract

backgroundCertain bacterial infectious diseases are categorized as notifiable infectious diseases in China. Understanding the time-varying epidemiology of bacterial infections diseases can provide scientific evidence to inform prevention and control measures.

methodsYearly incidence data for all 17 major notifiable bacterial infectious diseases (BIDs) at the province level were obtained from the National Notifiable Infectious Disease Reporting Information System in China between 2004 and 2019. Of them 16 BIDs are divided into four categories, respiratory transmitted diseases (RTDs, 6 diseases), direct contact/fecal-oral transmitted diseases (DCFTDs, 3 diseases), blood-borne/sexually transmitted diseases (BSTDs, 2 diseases), and zoonotic and vector-borne diseases (ZVDs, 5 diseases), and neonatal tetanus is excluded in the analysis. We characterized the demographic, temporal, and geographical features of the BIDs and examined their changing trends using a joinpoint regression analysis.

resultsDuring 2004‒2019, 28 779 thousand cases of BIDs were reported, with an annualized incidence rate of 134.00 per 100 000. RTDs were the most commonly reported BIDs, accounting for 57.02% of the cases (16 410 639/28 779 000). Average annual percent changes (AAPC) in incidence were - 1.98% for RTDs, - 11.66% for DCFTDs, 4.74% for BSTDs, and 4.46% for ZVDs. Females had a higher incidence of syphilis than males, and other BIDs were more commonly reported in males. Among 0-5-year-olds, the diseases with the largest increases in incidence were pertussis (15.17% AAPC) and scarlet fever (12.05%). Children and students had the highest incidence rates of scarlet fever, pertussis, meningococcal meningitis, and bacillary dysentery. Northwest China had the highest incidence of RTDs, while South and East China had the highest incidences of BSTDs. Laboratory confirmation of BIDs increased from 43.80 to 64.04% during the study period.

conclusionsRTDs and DCFTDs decreased from 2004 to 2019 in China, while BSTDs and ZVDs increased during the same period. Great attention should be paid to BSTDs and ZVDs, active surveillance should be strengthened, and timely control measures should be adopted to reduce the incidence.

Indexed as

Communicable DiseasesScarlet FeverWhooping CoughChildChild, PreschoolChinaFemaleHumansIncidenceInfant, NewbornMaleBacterial infectious diseasesIncidenceJoinpoint regressionLaboratory confirmation

Identifiers

PMID37131164
PMCPMC10152418
OpenAlexW4367834510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.